Xarelto Lawsuit Plaintiffs Question Drug’s Safety While Alternative Therapies Emerge

September 30, 2016 – – TheProductLawyers.com reports on alternatives to using blood-thinning drugs in light of the surging controversy surrounding Xarelto and its alleged dangerous side effects as well as dubious clinical trial results due to the use of a recalled medical device. As per an article in SBWire, Greg Grambor, President of Vascular PRN, is offering patients at an increased risk of blood clots an alternative preventative option in lieu of drugs like Xarelto. His company is a distributor of pneumatic compression devices, an option that could offer patients a blood clotting therapy that offers preventative protection without the potentially dangerous risks that come with using Xarelto and other similar drugs. Such devices use alternating compression to increase blood flow and thus prevent clotting in patients recovering from surgery or those in nursing homes that are immobile.

Xarelto has become immersed in controversy since it was approved by the U.S. Food and Drug Administration in 2011. It, and its manufacturers, Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer AG, are the focus of more than 3,000 lawsuits, 2,800 of which are federal cases that have been consolidated in a multidistrict litigation (MDL 2592) by the U.S. Judicial Panel on Multidistrict Litigation and is being overseen by a judge in the Eastern District of Louisiana. Another consolidation of 600 cases has occurred in Philadelphia, PA by the Court of Common Pleas. It is expected that more cases will be added to both groups as time goes on.

Since its release the drug is perceived by many patients and others as being very dangerous since it is alleged to have caused excessive and sometimes fatal bleeding. Plaintiffs in many of the lawsuits have alleged that manufacturers used misleading marketing and advertising tactics to sell the anticoagulant. Adding to the controversy over the drug as well is the investigation into the use of a faulty medical device used in clinical trials that made Xarelto seem more effective than it really was. This erroneous data was sent to reputable medical journals.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012382